Zealand Pharma Stock News

Healthcare > Biotechnology

Buy ZEAL

*Your capital is at risk

$17.59

+0 (+0%)

At Close: Jan 27, 2023

Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022

04:00am, Thursday, 03'rd Nov 2022

Company announcement – No. 49 / 2022

Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

11:00am, Wednesday, 07'th Sep 2022

Press release – No. 4 / 2022

Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q2 2022 Results - Earnings Call Transcript

01:16pm, Thursday, 11'th Aug 2022

Zealand Pharma A/S (ZEAL) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Anna Krassowska - VP of IR and Corporate Communications Adam Steensberg - President and CEO

Zealand Pharma AS (ZEAL) Stock Jumps 9.1%: Will It Continue to Soar?

10:07am, Thursday, 21'st Jul 2022

Zealand Pharma AS (ZEAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength do

Zealand Pharma to Participate in Upcoming Investor Conferences

08:30am, Friday, 03'rd Jun 2022

Press release – No. 3 / 202 2

Why Zealand Pharma Shares Are Rising

10:41am, Thursday, 19'th May 2022

Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenit

Zealand Pharma's Dasiglucagon Aces Late-Stage Study In Pediatric Patients, Shares Move Higher

09:53am, Thursday, 19'th May 2022

Zealand Pharma A/S (NASDAQ: ZEAL) has announced topline results from its second Phase 3 trial of dasiglucagon in pediatric patients with congenital hyperinsulinism (CHI), a condition in which indiv

Zealand Pharma to seek FDA approval of its treatment for rare genetic disorder in babies

08:48am, Thursday, 19'th May 2022

U.S.-listed shares of Zealand Pharma ZEAL, +1.83% ZEAL, +18.99% soared 21.2% in premarket trading on Thursday after the company said a Phase 3 clinical trial evaluating its investigational treatment f

Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q1 2022 Earnings Call Transcript

04:06pm, Thursday, 12'th May 2022

Zealand Pharma A/S (ZEAL) Q1 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Matt Dallas - SVP and CFO Adam Steensberg - President and CEO Conference Call Participants Thom